PATENT CLAIM ANALYSIS

Application Number: 15971496
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "603000"]

Abstract:
A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.

Claim (Index 12):
The method of  claim 1 , wherein the compound is a compound of Formula IV or a prodrug, therapeutically active metabolite, hydrate, solvate, or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13180144', '12143664', '13141310', '15263033', '15778207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7989578155587295
- 35 USC 102 Novelty (BERT): 0.5238512254226277
- Combined Prediction Score: 0.7714471565451193
- Mean Citation Score: 317.843784
- Max Citation Score: 333.9717
- Similarity Product: 258.44860632276533

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test